Jeffrey Balzer, PhD

Associate Professor of Neurological Surgery, Neuroscience & Acute and Tertiary Care Nursing
Associate Director for Clinical Services
Director of Cerebral Blood Flow Laboratory





Jeffrey Balzer, PhD, is associate director for clinical services and staff clinical neurophysiologist at the Center for Clinical Neurophysiology and director of the Cerebral Blood Flow Laboratory at the University of Pittsburgh Medical Center.

His current research interests range from the prediction of stroke risk in cerebrovascular disease to the use of blood flow measures in mild head injury and concussion to vagal nerve stimulation to control cardiac arythmias. Dr. Balzer received his undergraduate education at the University of Pittsburgh, where he also pursued a graduate education and a PhD in behavioral neuroscience.

Dr. Balzer is also the secretary/treasurer of the American Board of Neurophysiological Monitoring.

He has published 37 refereed articles and 11 book chapters.

Dr. Balzer's publications can be reviewed through the National Library of Medicine's publication database.

Board Certifications

American Board of Neurophysiological Monitoring

Hospital Privileges

Children’s Hospital of Pittsburgh of UPMC
Jameson Hospital
Magee-Womens Hospital of UPMC
Mon Valley Hospital
UPMC Hamot
UPMC Horizon
UPMC McKeesport
UPMC Mercy
UPMC Passavant
UPMC Presbyterian
UPMC St. Margaret’s
UPMC Shadyside

Professional Organization Membership

American Clinical Neurophysiology Society
American Association for the Advancement of Science
American Society for Neurophysiological Monitoring (Fellow)
New York Academy of Sciences
Pittsburgh Neuroscience Society

Research Activities

As a co-investigator on an NINR grant exploring genetic and biomarker predictors of delayed cerebral ischemia and long term outcomes after aSAH, this past year has been very productive. Dr. Balzer’s group has shown that CSF 20-HETE is associated with delayed cerebral ischemia and poor outcomes after aSAH, defined the relationship between mean arterial pressure and cerebral blood flow velocities in patients with aSAH, as well as showing that transcranial regional cerebral oxygen desaturation predicts delayed cerebral ischemia and poor outcomes after subarachnoid hemorrhage. Most recently, they have shown how cerebral perfusion pressure is associated with delayed cerebral ischemia after aSAH as well as well as defining the temporal profiles of cerebral perfusion pressure after subarachnoid hemorrhage.

In addition to his research on aSAH, Dr. Balzer has continued his collaboration with interventional cardiology investigating the feasibility of vagal stimulation from within the right internal jugular (RIJ) or brachiocephalic (BC) vein and assessing the downstream neurohormonal and cardiac electrophysiological (EP) effects. Thus far Dr. Balzer and collaborators have found that endovascular vagal stimulation is feasible. However, epinephrine and norepinephrine results may indicate mixed autonomic neuromodulation effects.